Autoinjectors Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027Price: 3200/- USD | Published Date: October 11, 2020 |
The global autoinjectors market size is projected to grow at the CAGR of 17.0 % market during the forecast period 2020-2027. With the rising trend towards self-administration of drugs, injectable drug delivery solutions such as autoinjectors and pen injectors demonstrate a noteworthy growth potential in the near future. Driven by industry demands, biopharmaceutical companies worldwide have since introduced a big range of drug injection solutions. In fact, it is also estimated that a significant section of new product entries to the FDA will be drug-device combinations.
The rising trend of self-administration of drugs and fewer clinic visits are the key growth factors in the autoinjectors market. In 2019, Manual injectors is the largest segment in the considered device categories. Offered benefits over conventional self-injection systems such as overcoming the risk of needle-stick injury, treatment compliance. Reduced need to visit clinics has led to an overall reduction in treatment costs and improved treatment outcomes. Anaphylaxis held the largest market in the therapeutic area due to factors such as patients with allergies who are at a higher risk of having severe reactions i.e. anaphylaxis. The autoinjectors market is currently dominated by North America due to the increasing number of patients suffering from allergic reactions, increasing demand for self-administration of drugs and supportive reimbursement policies. On the other hand, Asia Pacific is anticipated to be the fastest-growing market because of deep market penetration due to the presence of multiple players involved in autoinjectors manufacture, increasing prevalence of allergic reaction, and developing healthcare infrastructure.
Market Segment Insights:
The autoinjectors market is majorly segmented into devices: manual injection autoinjectors, automated injection autoinjectors, reusable autoinjectors, disposable autoinjectors, variable dose autoinjectors, and smart autoinjectors. Among these, manual injection autoinjectors held the largest market in the device segment due to growth factors such as no risk of needle-stick injury, minimum clinic visit has led to the overall reduction in treatment costs and improved treatment outcomes. Therapeutic areas consist of anaphylaxis, anticoagulants, autoimmune diseases, emergency medicine, infectious diseases, hematopoietic, hormones, neurology, and reproductive health. Anaphylaxis held the largest share in the therapeutic segment primarily due to the increasing prevalence of allergic reaction requiring immediate medical relief.
Global Autoinjectors Market Segmentation:
By Device, 2018–2027 ($ Million)
- Manual Injection Autoinjectors
- Automated Injection Autoinjectors
- Reusable Autoinjectors
- Disposable Autoinjectors
- Variable Dose Autoinjectors
- Smart Autoinjectors
By Therapeutic Area, 2018–2027 ($ Million)
- Emergency Medicine
- Autoimmune Diseases
- Infectious Diseases
- Reproductive Health
By Geography, 2018-2027 ($ Million)
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
North America, Latin America, Europe, Middle East and Africa, and Asia Pacific, markets together form the major regional markets for autoinjectors. These regional markets are further sub-segmented into country-specific markets on the basis of demand and market growth of autoinjectors. Among the considered regional markets, North America currently dominates the global autoinjectors market, with the United States being the largest county-level market due to the increasing trend of self-administration of drugs, early disease diagnosis, and supportive reimbursement policies. Additionally, Asia Pacific is anticipated to be the fastest-growing market for autoinjectors due to the huge population base suffering from allergic reactions, rising public awareness, and high disposable income.
Market Competition Assessment:
Key players in the global autoinjectors market are Antares Pharma, Inc., Bayer AG, Biogen Idec, Inc. Becton, Dickinson and Company, Emergent BioSolutions, Mylan, Inc., Novartis International AG, Pfizer, Inc., Sanofi S. A., Scandinavian Health Ltd. Unilife Corporation, Ypsomed Holding AG, and others.
List of Key Companies:
- Antares Pharma, Inc.
- Bayer AG
- Becton, Dickinson and Company
- Biogen Idec, Inc.
- Emergent BioSolutions
- Mylan, Inc.
- Novartis International AG
- Pfizer, Inc.
- Sanofi S. A.
- Scandinavian Health Ltd.
- Unilife Corporation
- Ypsomed Holding AG
- Other Notable Players
Key Questions Answered by Autoinjectors Market Report
- Global autoinjectors market forecasts from 2020-2027
- Regional autoinjectors market forecasts from 2020-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
- Country level forecasts from 2020-2027 covering 15 major countries from the aforementioned regions
- Autoinjectors submarket forecasts from 2020-2027 covering the market by device, by therapeutics area, and geography
- Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to autoinjectors market
- Analysis of the key factors driving and restraining the growth of the global, regional, and country-level autoinjectors markets from 2020-2027
- Competitive Landscape and market positioning of top 10 players operating in the autoinjectors market
Request a full report sample @ https://www.researchcorridor.com/request-sample/?id=39824
Table of Content:
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Autoinjectors Market, by Devices, 2019 ($ Million)
2.2 Autoinjectors Market Share, by Therapeutic Area, 2019 ($ Million)
2.3 Autoinjectors Market Share, by Geography, 2019 (Value %)
Chapter 3 Autoinjectors Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.5 Major Market Events Assessment
3.6 Attractive Investment Proposition
3.7 Competitive Analysis: Autoinjectors Market, by Key Market Players
Chapter 4 Global Autoinjectors Market Analysis, by Devices, 2018 - 2027 ($ Million)
4.2 Manual Injection Autoinjectors
4.3 Automated Injection Autoinjectors
4.4 Reusable Autoinjectors
4.5 Disposable Autoinjectors
4.6 Variable Dose Autoinjectors
4.7 Smart Autoinjectors
Chapter 5 Global Autoinjectors Market Analysis, by Therapeutic Area, 2018 – 2027 ($ Million)
5.4 Autoimmune Diseases
5.5 Emergency Medicine
5.6 Infectious Diseases
5.10 Reproductive Health
Chapter 6 Global Autoinjectors Market, by Geography, 2018-2027 ($ Million)
6.1. North America
6.2.3. Rest of Europe
6.3. Asia Pacific
6.3.3. Rest of Asia Pacific
6.4. Latin America
6.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.2. Rest of Middle East and Africa
Chapter 7 Company Profiles
7.1. Antares Pharma, Inc.
7.2. Bayer AG
7.3. Becton, Dickinson and Company
7.4. Biogen Idec, Inc.
7.5. Emergent BioSolutions
7.6. Mylan, Inc.
7.7. Novartis International AG
7.8. Pfizer, Inc.
7.9. Sanofi S. A.
7.10. Scandinavian Health Ltd.
7.11. Unilife Corporation
7.12. Ypsomed Holding AG
$4800/- Multi User License $6400/- Corporate License
- Markets in over 150 countries analyzed granularly
- 35% of our total client base has an annual subscription membership
- 100,000+ data points in our comprehensive database
- 24x5 availability - we are always there when you need us
- Our expert team will assist you with all research need and customization
- Our expert research analysts will resolve your every query before and after purchasing the report
- We focus on the accuracy and quality of the report
- Our analyst will provide deep insights into the report
Contact Person: Vijendra Singh